| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/25/2002 | WO2001083740A3 Splice-region antisense composition and method |
| 04/25/2002 | WO2001080897A3 Compositions and methods for in vivo delivery of polynucleotide-based therapeutics |
| 04/25/2002 | WO2001073073A3 Regulation of human neutral protease-related enzyme |
| 04/25/2002 | WO2001068889A3 Method for gene transfection and vaccination through skin using electropermeabilization |
| 04/25/2002 | WO2001060975A3 Gene disruption methodologies in fungi for drug target discovery |
| 04/25/2002 | WO2001060847A3 avirulent, immunogenic flavivirus chimeras |
| 04/25/2002 | WO2001059102A3 Nucleozymes with endonuclease activity |
| 04/25/2002 | WO2001058940A3 Adenoviral capsid containing chimeric protein IX |
| 04/25/2002 | WO2001052904A3 Pharmaceutical compositions and methods of treatment based on VEGF antisense oligonucleotides |
| 04/25/2002 | WO2001042471A3 Polypeptides and polynucleotides encoding same |
| 04/25/2002 | WO2001041810A3 Nucleic acid delivery system |
| 04/25/2002 | WO2000029622A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 04/25/2002 | US20020049404 Fas ligand expressing antigen presenting cells for tolerance induction |
| 04/25/2002 | US20020049313 Method for introducing foreign material into higher eukaryotic cells |
| 04/25/2002 | US20020049181 Novel internal ribosome entry site, vector containing same and uses thereof |
| 04/25/2002 | US20020049180 KIAA0175 inhibitor is selected from the group consisting of an anti-sense molecule, a ribozyme, an antibody, an antibody fragment, a protein, a polypeptide and a small molecule. |
| 04/25/2002 | US20020049179 Isolation of a cDNA encoding a novel protein tyrosine phosphatase which localized to focal adhesions and uses therefor |
| 04/25/2002 | US20020049178 Injecting a nucleic acid construct encoding a neurotrophic factor into a subject's brain. |
| 04/25/2002 | US20020049177 Detecting an aberrant level or bioactivity of or screening for a Wnt pathway component or a frizzled related protein gene product |
| 04/25/2002 | US20020049174 First region is available for hybridization and the second region is temporarily masked. |
| 04/25/2002 | US20020049154 Bioconjugates and delivery of bioactive agents |
| 04/25/2002 | US20020049151 Therapeutic approaches to diseases by suppression of the NURR subfamily of nuclear transcription factors |
| 04/25/2002 | US20020048815 Modified lepidopteran receptors and hybrid multifunctional proteins for use in transcription and regulation of transgene expression |
| 04/25/2002 | US20020048805 Feline immunodeficiency virus gene therapy vectors |
| 04/25/2002 | US20020048790 Nucleotide sequences coding binding protein for use in the prevention of infections; bactericides |
| 04/25/2002 | US20020048789 birA |
| 04/25/2002 | US20020048786 Nucleotide sequences for use in the treatment of infections, arthritis, karposi's sarcoma, allergies, asthma, nervous system and autoimmune diseases |
| 04/25/2002 | US20020048785 Novel polypeptides within the tumor necrosis factor receptor superfamily and uses therefor |
| 04/25/2002 | US20020048764 Human PEM as a target for birth contol and treatment of Alzheimer's disease |
| 04/25/2002 | US20020048585 Decreasing syndecan-4 expression, level, or activity |
| 04/25/2002 | US20020048571 Chimeric polypeptides of serum albumin and uses related thereto |
| 04/25/2002 | US20020048566 Modulation of cellular apoptosis and methods for treating cancer |
| 04/25/2002 | US20020048565 Mammalian tolloid-like gene and protein |
| 04/25/2002 | DE10045123A1 New transcription factor gene from Candida albicans, and its related polypeptide and antibody, useful for diagnosis and treatment of candida infection and for drug screening |
| 04/25/2002 | CA2818654A1 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | CA2464121A1 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | CA2426460A1 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 04/25/2002 | CA2426403A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis |
| 04/25/2002 | CA2426198A1 Zipper protein kinase and uses thereof |
| 04/25/2002 | CA2425669A1 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 04/25/2002 | CA2425174A1 Human gene critical to fertility |
| 04/25/2002 | CA2405906A1 Remedies or preventives for rheumatoid arthritis |
| 04/24/2002 | EP1199368A2 Use of adenoviral e4 reading frames to improve expression of a gene of interest |
| 04/24/2002 | EP1199363A1 Phosphorylation modifications of apoptin |
| 04/24/2002 | EP1199360A2 Active and inactive CC-chemokine receptors and nucleic acid molecules encoding said receptor |
| 04/24/2002 | EP1199358A1 Gene encoding promoter domain of tumor suppressor gene p51 and use thereof |
| 04/24/2002 | EP1198581A1 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 04/24/2002 | EP1198580A1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/24/2002 | EP1198579A1 Non-human adenoviral vector for gene transfer, its use and the production thereof |
| 04/24/2002 | EP1198570A1 Monomeric protein of the tgf-beta family |
| 04/24/2002 | EP1198563A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 04/24/2002 | EP1198560A2 Mammalian adhesion protease peptides |
| 04/24/2002 | EP1198556A2 Methods for producing and preparing cells for cell therapy |
| 04/24/2002 | EP1198489A1 Combinations for introducing nucleic acids into cells |
| 04/24/2002 | EP1198479A1 Neovascular-targeted immunoconjugates |
| 04/24/2002 | EP1198256A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 04/24/2002 | EP1198248A2 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment |
| 04/24/2002 | EP1198241A1 Novel proteins |
| 04/24/2002 | EP1198239A1 Methods employing bacterial toxin-antitoxin systems for killing eukaryotic cells |
| 04/24/2002 | EP0863911B1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 04/24/2002 | CN1346406A Human ubiquitin ligase E3 for the modulation of NF-kappa 8 |
| 04/24/2002 | CN1346370A Polypeptides involved in immune response |
| 04/24/2002 | CN1346366A Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 04/24/2002 | CN1346363A The novel antisense-oligos with better stability and antisense effect |
| 04/24/2002 | CN1346290A Delivery of macromolecules into cells |
| 04/24/2002 | CN1346284A CD 40 binding molecules and CTL peptides for treating tumors |
| 04/23/2002 | US6376661 Human RNase H and compositions and uses thereof |
| 04/23/2002 | US6376653 Tie2 antagonist antibodies |
| 04/23/2002 | US6376508 Treatments for spinal muscular atrophy |
| 04/23/2002 | US6376475 Inhibiting biosynthesis of sialyl galactosides involved in immune responses; for treating graft rejection, autoimmune diseases, and allergies |
| 04/23/2002 | US6376471 Gene delivery compositions and methods |
| 04/23/2002 | US6376463 Modified factor VIII |
| 04/23/2002 | US6376248 Peptide-enhanced transfections |
| 04/23/2002 | US6376243 Capable of specifically hybridizing with a sequence included within the sequence of a nucleic acid molecule encoding a mammalian 5-ht4b receptor. |
| 04/23/2002 | US6376239 DNA molecules comprising a promoter capable of conferring expression of a heterologous DNA sequence |
| 04/23/2002 | US6376236 Alphavirus vector construct which directs the expression of a heterologous nucleic acid molecule; capsid protein; and envelope glycoprotein from a second virus different from the alphavirus of said alphavirus vector construct |
| 04/23/2002 | US6376196 Contacting sample with isolated immunodominant neospora antigen, thereby forming antigen/antibody complex and detecting presence of antibodies specifically immunoreactive with bovine neospora antigen |
| 04/23/2002 | US6376175 Contacting cell which is capable of expressing gene with amount of molecule effective to transcriptionally modulate expression of gene and thereby affect level of protein encoded by gene which is expressed by cell |
| 04/23/2002 | US6376174 Nucleic acid encoding Schwannomin-Binding-Proteins and products related thereto |
| 04/23/2002 | US6375980 Stabilization of lipid:DNA formulations during nebulization |
| 04/23/2002 | US6375975 Pharmaceutical compositions for buccal and pulmonary application |
| 04/23/2002 | US6375929 Gene therapy for inhibition of angiogenesis |
| 04/18/2002 | WO2002031498A2 Protecting therapeutic compositions from host-mediated inactivation |
| 04/18/2002 | WO2002031201A2 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 04/18/2002 | WO2002031180A2 Flea peritrophin nucleic acid molecules, proteins and uses thereof |
| 04/18/2002 | WO2002031162A2 Regulation of human phospholipase a2-like enzyme |
| 04/18/2002 | WO2002031151A2 Lipocalins |
| 04/18/2002 | WO2002031145A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/18/2002 | WO2002031144A2 Identification of cytotoxic activity from the ink of aplysia punctata |
| 04/18/2002 | WO2002031138A1 Paramyxovirus vector for transferring foreign gene into skeletal muscle |
| 04/18/2002 | WO2002031136A1 Antisense modulation of bcas1 expression |
| 04/18/2002 | WO2002031128A1 Methods of agonizing and antagonizing fabk |
| 04/18/2002 | WO2002031126A2 Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase |
| 04/18/2002 | WO2002031116A2 Gene expression modulated in spontaneous inflammatory bowel disease |
| 04/18/2002 | WO2002031110A2 Hematopoietic stem cell gene therapy |
| 04/18/2002 | WO2002031109A2 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 04/18/2002 | WO2002031025A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 04/18/2002 | WO2002030979A2 Polypeptides homologous to thymosin, ephrin a receptors, and fibromodulin, and polynucleotides encoding same |
| 04/18/2002 | WO2002030974A2 Proteins and nucleic acids encoding same |
| 04/18/2002 | WO2002030970A2 Human histone deacetylase gene |